Sotagliflozin Reduces Risk for Adverse CV Events in Diabetic Kidney Disease
Sotagliflozin might help patients with diabetes and chronic kidney disease who are hospitalized with heart failure avoid a readmission, study results suggest.
Chronic Kidney Disease
Nephropathy Progression in Type 1 Diabetes Linked to Depression
Whether successful treatment of depression reduces the risk for progression needs to be determined.
Kidney Disease Associated With Greater Likelihood of Major Surgeries
In a large population-based study, patients on dialysis had the highest incidence rates for major surgeries.
New Equation Estimates GFR Across Age Spectrum
But EKFC equation was developed and validated only in White populations.
Finerenone NDA Submitted for Diabetic Kidney Disease
The NDA for finerenone is supported by data from the double-blind, placebo-controlled phase 3 FIDELIO-DKD trial.
Highlights From the New KDIGO Guideline on Diabetes and CKD
The new KDIGO guideline highlights specific management differences by CKD severity.
Infections Common in Glomerular Disease Population
Investigators identify risks factors for infection-related acute care events in children and adults with glomerular disease.
Moderate to Severe CKD Shown to Worsen VTE Prognosis
In a study, patients with moderate to severe CKD vs mild or no CKD had increased risk for death and recurrent venous thromboembolism.
Removing Race Classifier Would Impact Care in Blacks With CKD
About 1 in 3 patients would be reclassified to more severe chronic kidney disease stage.
Alpha Blockers Linked to Higher Risk for Kidney Disease Progression
New findings could allow clinicians to have more nuanced discussions with patients who have chronic kidney disease regarding the long-term risks associated with alpha blocker use to control blood pressure.
-
Loading...
-
Loading...
Next post in Hypertension
